Cargando…

Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy

A treatment strategy based on the distance of mesorectal extension (DME) for pT3N1-2 rectal cancer patients without pre-operative chemoradiotherapy has not yet been defined. The present study aimed to describe the benefit of the measurement of mesorectal extension in stratifying treatment for pT3N1-...

Descripción completa

Detalles Bibliográficos
Autores principales:	AKAGI, YOSHITO, SHIROUZU, KAZUO, FUJITA, SHIN, UENO, HIDEKI, TAKII, YASUMASA, KOMORI, KOJI, ITO, MASAAKI, SUGIHARA, KENICHI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570185/ https://www.ncbi.nlm.nih.gov/pubmed/23407463 http://dx.doi.org/10.3892/etm.2012.858

Ejemplares similares

Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer
por: Akagi, Yoshito, et al.
Publicado: (2013)

Intersphincteric resection for very low rectal cancer: A review of the updated literature
por: Shirouzu, Kazuo, et al.
Publicado: (2017)

Short-term safety of adjuvant chemoradiotherapy after local resection for patients with high-risk submucosal invasive rectal cancer: a single-arm, multicenter phase II trial
por: Noguchi, Masaaki, et al.
Publicado: (2021)

Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy
por: Yeo, Seung-Gu, et al.
Publicado: (2013)

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
por: Solanki, Abhishek A, et al.
Publicado: (2013)

In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer
por: Wu, Jun-xin, et al.
Publicado: (2014)

Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy
por: Lino-Silva, Leonardo S., et al.
Publicado: (2016)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

Transanal Total Mesorectal Excision for Rectal Cancer: Toward Standardization of the Surgical Technique
por: Kitaguchi, Daichi, et al.
Publicado: (2023)

The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study
por: Akgun, Erhan, et al.
Publicado: (2017)

Local Excision ± Chemoradiotherapy vs. Total Mesorectal Excision for Early Rectal Cancer: Case-Matched Analysis of Long-Term Results
por: Pacevicius, Julius, et al.
Publicado: (2021)

Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy
por: Sakamoto, Wataru, et al.
Publicado: (2021)

Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?
por: Glimelius, Bengt
Publicado: (2014)

Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk
por: Lai, I-Li, et al.
Publicado: (2019)

Identification of high-risk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution
por: YAMAGUCHI, KEIZO, et al.
Publicado: (2013)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)

Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision
por: Zuo, Zhi-Gui, et al.
Publicado: (2016)

Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer
por: Lee, Ja Kyung, et al.
Publicado: (2021)

Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study
por: Guan, Bingjie, et al.
Publicado: (2022)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Optimal bowel resection margin in colon cancer surgery: prospective multicentre cohort study with lymph node and feeding artery mapping
por: Ueno, Hideki, et al.
Publicado: (2023)

Voiding Dysfunction after Total Mesorectal Excision in Rectal Cancer
por: Kim, Jae Heon, et al.
Publicado: (2011)

Transanal total mesorectal excision and transabdominal robotic surgery for rectal cancer: A retrospective study
por: Oshio, Hiroshi, et al.
Publicado: (2021)

Operative blood loss and use of blood products after full robotic and conventional low anterior resection with total mesorectal excision for treatment of rectal cancer
por: Biffi, Roberto, et al.
Publicado: (2010)

The Value of High-Resolution MRI Technique in Patients with Rectal Carcinoma: Pre-Operative Assessment of Mesorectal Fascia Involvement, Circumferential Resection Margin and Local Staging
por: Algebally, Ahmed Mohamed, et al.
Publicado: (2015)

Comparison of the operative outcomes and learning curves between laparoscopic and “Micro Hand S” robot-assisted total mesorectal excision for rectal cancer: a retrospective study
por: Wang, Yanlei, et al.
Publicado: (2021)

Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
por: Lee, Jii Bum, et al.
Publicado: (2021)

A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy
por: Yu, Guilin, et al.
Publicado: (2021)

Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision
por: Zhao, Jieyi, et al.
Publicado: (2022)

Female urogenital dysfunction following total mesorectal excision for rectal cancer
por: Daniels, Ian R, et al.
Publicado: (2006)

Transumbilical laparoendoscopic single-site total mesorectal excision for rectal carcinoma
por: Michalik, Maciej, et al.
Publicado: (2012)

Transanal Total Mesorectal Excision With Single-Incision Laparoscopy for Rectal Cancer
por: Foo, Dominic Chi-chung, et al.
Publicado: (2016)

Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018)

From Total Mesorectal Excision to Organ Preservation for the Treatment of Rectal Cancer
por: Baek, Seong Kyu
Publicado: (2019)

Comparing outcomes of robotic versus open mesorectal excision for rectal cancer
por: Jimenez-Rodriguez, Rosa M, et al.
Publicado: (2022)

Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
por: Maykel, Justin A., et al.
Publicado: (2022)

Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer
por: Caycedo-Marulanda, Antonio, et al.
Publicado: (2021)

Learning Curve of Robotic-Assisted Total Mesorectal Excision for Rectal Cancer
por: Tang, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2eb3qqfma24cee7oltqc2hrqlb